priority health glp-1 coverage How to Manage Without Breaking the Bank Coverage of Obesity Therapies in
Description
For people who are on GLP-1 agonists like Ozempic and thinking about having kids, a lot is still unknown
N = 161,798 after matching GLP-1RA vs diet/exercise consultation Median follow-up: 2 years Key result: Any obesity-associated cancer HR 0.59, 95% CI 0.53-0.67 Site-specific signals: Multiple myeloma HR 0.37 Pancreatic cancer HR 0.40 Endometrial cancer HR 0.42 Colorectal cancer HR 0.49 But remember: This is observational
Ozempic vs Zepbound compared head-to-head: the SURMOUNT-5 trial shows tirzepatide (20.2%) beats semaglutide (13.7%) for weight loss
GLP-1 research peptides with 99% purity, third-party tested for quality and consistency
